ZA200807993B - A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation - Google Patents

A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation

Info

Publication number
ZA200807993B
ZA200807993B ZA200807993A ZA200807993A ZA200807993B ZA 200807993 B ZA200807993 B ZA 200807993B ZA 200807993 A ZA200807993 A ZA 200807993A ZA 200807993 A ZA200807993 A ZA 200807993A ZA 200807993 B ZA200807993 B ZA 200807993B
Authority
ZA
South Africa
Prior art keywords
disorders
treatment
protein aggregation
cyclohexane polyalcohol
polyalcohol formulation
Prior art date
Application number
ZA200807993A
Inventor
Joanne Mclaurin
Antonio Cruz
Original Assignee
Waratah Pharmaceuticals Inc
Joanne Mclaurin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Waratah Pharmaceuticals Inc, Joanne Mclaurin filed Critical Waratah Pharmaceuticals Inc
Publication of ZA200807993B publication Critical patent/ZA200807993B/en

Links

ZA200807993A 2006-03-09 2007-03-09 A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation ZA200807993B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78052606P 2006-03-09 2006-03-09

Publications (1)

Publication Number Publication Date
ZA200807993B true ZA200807993B (en) 2010-02-24

Family

ID=40977597

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200807993A ZA200807993B (en) 2006-03-09 2007-03-09 A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation

Country Status (2)

Country Link
CN (1) CN101505741A (en)
ZA (1) ZA200807993B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103906520A (en) * 2011-06-03 2014-07-02 伊兰制药公司 Scyllo-inositol for the treatment of behavioral and psychiatric disorders
CN104869993B (en) * 2012-10-25 2019-01-15 通用医疗公司 The combination treatment for treating Alzheimer disease and related disease

Also Published As

Publication number Publication date
CN101505741A (en) 2009-08-12

Similar Documents

Publication Publication Date Title
ZA200908303B (en) A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation
EP2010187A4 (en) Compounds for diseases and disorders
IL213341A0 (en) Dipeptide linked medicinal agents
ZA200809528B (en) Treatment for depressive disorders
IL194123A0 (en) Methods for reducing protein aggregation
HK1158172A1 (en) Compounds for treating ophthalmic diseases and disorders
PT2004155T (en) Inhibitors of protein aggregation
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
ZA200809527B (en) Treatment for depressive disorders
EP2139475A4 (en) The use of pde7 inhibitors for the treatment of movement disorders
HK1247943A1 (en) Treatment of development-related disorders
GB0915259D0 (en) Sulphur-linked compounds for treating ophthalmic diseases and disorders
IL192415A0 (en) Pharmaceutical composition for the treatment of nail diseases
PL2341047T3 (en) Cyclohexane derivative and pharmaceutical use thereof
EP2077838A4 (en) Methods for the treatment of a related disorders and compositions therefor
EP1988889A4 (en) Compositions and methods for treatment of ophthalmic diseases and disorders
EP1993523A4 (en) Compositions and methods for treatment of disorders of protein aggregation
GB2458868A8 (en) Treatment of protein aggregation diseases
EP2037943A4 (en) Treatment of connective tissue disorders
ZA200807993B (en) A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation
IL212719A0 (en) Gold nanoparticles coated with polyelectrolytes and use thereof as medicament for the treatment of neurodegenerative diseases caused by protein aggregates
PL1982178T3 (en) Methods for the treatment of affective disorders
EP2059238A4 (en) Therapeutic compounds for diseases and disorders
GB0616122D0 (en) Formulation for treatment of skin disorders
GB0526423D0 (en) Treatment of protein aggregation diseases